Journal of Affective Disorders
Volume 117, Issue 3 , Pages 174-179 , October 2009

Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination

  • Rachel E. Maddux

      Affiliations

    • Department of Psychology, Lund University, Lund, Sweden
    • ,
  • Lawrence P. Riso

      Affiliations

    • College of Psychology and Behavioral Sciences, Argosy University, Washington DC, United States
    • Corresponding Author InformationCorresponding author. Argosy University, 1550 Wilson Boulevard, Suite 600, Arlington, VA 22209. Tel.: +1 703 526 5852; fax: +1 703 243 8973.
    • ,
  • Daniel N. Klein

      Affiliations

    • Department of Psychology, Stony Brook University, Stony Brook, New York, United States
    • ,
  • John C. Markowitz

      Affiliations

    • Department of Psychiatry, Weill Medical College of Cornell University, New York, New York, United States
    • ,
  • Barbara O. Rothbaum

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, United States
    • ,
  • Bruce A. Arnow

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, United States
    • ,
  • Rachel Manber

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, United States
    • ,
  • Janice A. Blalock

      Affiliations

    • Department of Behavioral Science, University of Texas, Houston, Texas, United States
    • ,
  • Gabor I. Keitner

      Affiliations

    • Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States
    • ,
  • Michael E. Thase

      Affiliations

    • Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Received 26 August 2008 ,Revised 31 December 2008 ,Accepted 4 January 2009.

References 

  1. Akiskal HS, Bitar AH, Puzantian VR, Rosenthal TL, Walker PW. The nosological status of neurotic depression: a prospective 3–4 year follow-up examination in the light of the primary-secondary and the unipolar–bipolar dichotomies. Arch. Gen. Psychiatry. 1978;35(6):756–766
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. (4th ed.). Washington, DC: Author; 1994;
  3. Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response to major depression: a randomized controlled trial comparing cognitive–behavioural therapy and pharmacotherapy. Can. J. Psychiatry. 2008;53(6):361–370
  4. Brown GW, Moran P. Clinical and psychosocial origins of chronic depressive episodes I: a community survey. Br. J. Psychiatry. 1994;165(4):447–456
  5. Candrian M, Farabaugh A, Pizzagalli DA, Baer L, Fava M. Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study. J. of Nerv. Ment. Disord. 2007;195(9):729–737
  6. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr. Dev. 1986;4:167–226
  7. Compton MT, Rudisch BE, Weiss PS, West JC, Kaslow NC. Predictors of psychiatrist-reported treatment—compliance problems among patients in routine U.S. psychiatric care. Psychiatry Res. 2005;137:29–36
  8. Culpepper L. Chronic depression: treatment in primary care. Prim. Care Companion J. Clin. Psychiat. 2006;8(2):104–105
  9. Cyranowski JM, Frank E, Winter E, Rucci P, Novick D, Pilkonis P, et al. Personality pathology and outcome in recurrently depressed women over 2 years of maintenance interpersonal psychotherapy. Psychol. Med. 2004;34(4):659–669
  10. Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF. Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother. Psychosom. 1994;62:160–167
  11. Fava M, Farabaugh AH, Sickinger AH, Wright E, Alpert JE, Sonawalla S, et al. Personality disorders and depression. Psychol. Med. 2002;32(6):1049–1057
  12. First MB, Spitzer RL, Gibbon M, Williams JBW. In: The Structured Clinical Interview for DSM-IV AXIS I Disorders — Patient Edition (SCID-I/P, version 2.0). New York, NY: New York State Psychiatric Institute, Biometrics Research Department; 1995;
  13. First MB, Spitzer RL, Gibbon M, Williams JBW, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R personality disorders (SCID-II): Part II. Multisite test–retest reliability study. J. Pers. Disord. 1995;9:92–104
  14. Fournier J, DeRubeis RJ, Shelton RC, Gallop R, Amsterdam JD, Hollon SD. Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. Br. J. Psychiatry. 2008;192(2):124–129
  15. Friedman RA, Parides M, Baff R, Moran M, Kocsis J. Predictors of response to desipramine in dysthymia. J. Clin. Psychopharmcol. 1995;15:280–283
  16. Garyfallos G, Adamopoulou A, Karastergiou A, Voikli M, Sotiropoulou A, Donias S, et al. Personality disorders in dysthymia and major depression. Acta Psychiatr. Scand. 1999;99(5):332–340
  17. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  18. Hayden EP, Klein DN. Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. Am. J. Psychiatry. 2001;158(11):1864–1870
  19. Hirschfeld RMA. Personality disorders and depression: comorbidity. Depress. Anxiety. 1999;10(4):142–146
  20. Hirschfeld RMA, Russell JM, Delgoado PL, Fawcett J, Friedman RA, Harrison WM, et al. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J. Clin. Psychiatry. 1998;59:669–675
  21. Howland RH. Psychopharmacology of dysthymia. In:  Alpert J,  Fava M editor. Handbook of Chronic Depression: Diagnosis and Therapeutic Management. NY: Marcel Dekker; 2004;p. 139–158
  22. Ilardi SS, Craighead WE. Personality pathology and response to somatic treatments for major depression: a critical review. Depression. 1995;2:200–217
  23. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch. Gen. Psychiatry. 1998;55:694–700
  24. Keller MB, Gelenberg AJ, Hirschfeld RMA, Rush AJ, Thase ME, Kocsis JH, et al. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J. Clin. Psychiatry. 1998;59:598–607
  25. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New Engl. J. Med. 2000;342(20):1462–1470
  26. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;51(1):8–19
  27. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005;62:593–602
  28. Klein DN, Santiago NJ. Dysthymia and chronic depression: introduction, classification, risk factors, and course. J. Clin. Psychology. 2003;59(8):807–816
  29. Klein DN, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am. J. Psychiatry. 2000;157:931–939
  30. Klein DN, Durbin CE, Shankman SA, Santiago NJ. Depression and personality. In:  Gotlib IH,  Hammen CL editor. Handbook of Depression. NY: The Guilford Press; 2002;p. 115–140
  31. Klein DN, Schwartz JE, Santiago NJ, Vivian D, Vocisano C, Castonguay LG, et al. Therapeutic alliance in depression: controlling for prior change and patient characteristics. J. Consult. Clin. Psychol. 2003;71:997–1006
  32. Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am. J. Psychiatry. 2006;163:872–880
  33. Kocsis JH. Pharmacotherapy for chronic depression. J. Clin. Psychology. 2003;59(8):885–892
  34. Kool S, Schoevers R, de Maat S, Van R, Molenaar P, Vink A, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J. Affect. Disord. 2006;88:269–278
  35. Krishnan KRR. Comorbidity and depression treatment. Biol. Psychiatry. 2003;53(8):701–706
  36. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, et al. Interrater reliability and internal consistency of the Structured Clinical Interview for DSM-IV Axis II personality disorders (SCID-II), version 2.0. J. Pers. Disord. 1997;11(3):279–284
  37. Markowitz JC. Psychotherapy of dysthymic disorder. In:  Kocsis JH,  Klein DN editor. Diagnosis and Treatment of Chronic Depression. NY: Guilford Press; 1995;p. 146–168
  38. Markowitz JC, Moran ME, Kocsis JH, Frances AJ. Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J. Affect. Disord. 1992;24:63–71
  39. McCullough JP. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2000;
  40. McCullough JP. Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP). J. Clin. Psychology. 2003;59(8):833–846
  41. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am. J. Psychiatry. 2002;159(3):359–371
  42. Mulder RT, Joyce PR, Luty SE. The relationship of personality disorders to treatment outcome in depressed outpatients. J. Clin. Psychiatry. 2003;64:259–264
  43. Newman JR, Ewing SE, McColl RD, Borus JS, Nierenberg AA, Pava J, et al. Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J. Affect. Disord. 2000;57:241–247
  44. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br. J. Psychiatry. 2006;188(1):13–20
  45. Papakostas GI, Peterson TJ, Farabaugh AH, Murakami JL, Pava JA, Alpert JE, et al. Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder. J. Clin. Psychiatry. 2003;64:1357–1361
  46. Pepper CM, Klein DN, Anderson RL, Riso LP, Ouimette PC, Lizardi H. DSM-III-R axis II comorbidity in dysthymia and major depression. Am. J. Psychiatry. 1995;152(2):239–247
  47. Riso LP, Klein DN, Ferro T, Kasch KL, Pepper CM, Schwartz JE, et al. Understanding the comorbidity between early-onset dysthymia and cluster B personality disorders: a family study. Am. J. Psychiatry. 1996;153:900–906
  48. Riso LP, Miyatake RK, Thase ME. The search for determinants of chronic depression: a review of six factors. J. Affect. Disord. 2002;70(2):103–115
  49. Rothschild L, Zimmerman M. Personality disorders and the duration of depressive episode: a retrospective study. J. Pers. Disord. 2002;16(4):293–303
  50. Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RMA, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J. Clin. Psychiatry. 2003;64:554–561
  51. Ryder AG, Bagby RM. Diagnostic viability of depressive personality disorder: theoretical and conceptual issues. J. Pers. Disord. 1999;13:118–127
  52. Schulberg HC, Katon WJ, Simon GE, Rush AJ. Best clinical practice: guidelines for managing major depression in primary medical care. J. Clin. Psychiatry. 1999;60(suppl. 7):19–26
  53. Shea MT, Widiger TA, Klein MH. Comorbidity of personality disorders and depression: implications for treatment. J. Consult. Clin. Psychol. 1992;60:857–868
  54. Skodol AE, Grilo CM, Pagano ME, Bender DS, Gunderson JG, Shea MT, et al. Effects of personality disorders on functioning and well-being in major depressive disorder. J. Psychiatr. Pract. 2005;11:363–368
  55. Spitzer RL, Williams JBW, Gibbon M, First MB. In: Structured Clinician Interview for DSM-III-R Axis II Disorders (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.; 1990;
  56. Wells KB, Burnam MA, Rogers W, Hays R, Camp P. The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch. Gen. Psychiatry. 1992;49(10):788–794

PII: S0165-0327(09)00008-1

doi: 10.1016/j.jad.2009.01.010

Journal of Affective Disorders
Volume 117, Issue 3 , Pages 174-179 , October 2009

Article Tools